Botanix Pharmaceuticals Ltd BXPHF
$0.02
Last Updated: Aug 18, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
BXPHF Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Botanix Pharmaceuticals Ltd is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Botanix Pharmaceuticals Ltd. Stock Analysis BXPHF
United States Health Care Nano Cap Botanix Pharmaceuticals Ltd. is a dermatology company, which engages in the provision of business of researching and developing dermatology and antimicrobial products. The company is headquartered in Perth, Western Australia. The Company’s lead product is Sofdra (sofpironium) topical gel, 12.45%, a prescription anticholinergic medicine used on the skin (topical), to treat excessive underarm sweating (primary axillary hyperhidrosis) in adults and children nine years of age and older. Sofdra regulates sweating at the site of application, by binding to the primary sweat receptor and thereby blocking the sweat signal. Its product pipeline targets the various skin diseases, such as BTX 1503 for Acne, BTX 1702 for Rosacea, BTX 1204A for Atopic Dermatitis, and BTX 1801 for Hemodialysis Patients. Its BTX 1503 is a transdermal gel formulation for the treatment of serious acne in adults and teenagers. BTX 1702 is used for the treatment of papulopustular rosacea. BTX 1801 is an antimicrobial gel focused on targeting Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus (MRSA).
Botanix Pharmaceuticals Ltd (BXPHF) Chart
Financial Metrics & Statements of Botanix Pharmaceuticals Ltd (BXPHF)
FAQ's for Botanix Pharmaceuticals Ltd (BXPHF)
- As of August 2026, Botanix Pharmaceuticals Ltd BXPHF is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Botanix Pharmaceuticals Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Botanix Pharmaceuticals Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Botanix Pharmaceuticals Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Botanix Pharmaceuticals Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Botanix Pharmaceuticals Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Botanix Pharmaceuticals Ltd (BXPHF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
